Avalon Pharma signs MoU with Benta SAS to localize innovative products in Saudi Arabia

09:12 AM (Mecca time) Argaam
Logo ofMiddle East Pharmaceutical Industries Co. (Avalon Pharma)

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)

Middle East Pharmaceutical Industries Co. (Avalon Pharma) signed on Nov. 25 a two-year memorandum of understanding (MoU) with Benta SAS, for a partnership focused on localizing strategic and innovative products in Saudi Arabia.

 

The move aligns with Vision 2030 and the National Industrial Strategy, Avalon Pharma said in a statement on Tadawul today, Nov. 26.

 

The MoU sets a framework for collaboration in technology transfer, localization, and advanced technologies in manufacturing, combining Benta’s proven expertise and technical know-how with Avalon Pharma’s strong regulatory, manufacturing, and commercial foundation in the Kingdom.

 

There are no related parties to the MoU, the pharmaceutical producer added.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.